INDOUS
Start SIP
Invest Now
Start SIP in INDOUS
Performance
- Low
- ₹119
- High
- ₹124
- 52 Week Low
- ₹110
- 52 Week High
- ₹314
- Open Price₹124
- Previous Close₹122
- Volume21,728
Investment Returns
- Over 1 Month -0.2%
- Over 3 Month -11.13%
- Over 6 Month -18.89%
- Over 1 Year -58.49%
Smart Investing Starts Here Start SIP with Indo US Bio-Tech for Steady Growth!
Indo US Bio-Tech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 14.9
- PEG Ratio
- 0.3
- Market Cap Cr
- 252
- P/B Ratio
- 2.9
- Average True Range
- 6.72
- EPS
- 8.43
- Dividend Yield
- 0
- MACD Signal
- -1.88
- RSI
- 44.71
- MFI
- 59.02
Indo US Bio-Tech Financials
Indo US Bio-Tech Technicals
EMA & SMA
Current Price
₹125.40
+
3.2
(2.62%)
- Bearish Moving Average 0
- Bullish Moving Average 0
- 20 Day
- ₹124.34
- 50 Day
- ₹128.48
- 100 Day
- ₹136.81
- 200 Day
- ₹154.89
Resistance and Support
122.8
- R3 135.60
- R2 131.80
- R1 126.60
- S1 117.60
- S2 113.80
- S3 108.60
Indo US Bio-Tech Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results | |
| 2025-10-14 | Others | Inter-alia, to consider 1. Re-appointment of M/s. Gautam N Associates as a Statutory Auditors of the Company. 2. Approve Notice of Postal Ballot. 3. Other business matters. per share(2.5%)Interim Dividend |
| 2025-08-12 | Quarterly Results | |
| 2025-05-26 | Audited Results | |
| 2025-02-11 | Quarterly Results |
Indo US Bio-Tech F&O
About Indo US Bio-Tech
- NSE Symbol
- INDOUS
- BSE Symbol
- 541304
- Managing Director
- Mr. Jagdish Ajudia
- ISIN
- INE250Z01010
Similar Stocks to Indo US Bio-Tech
Indo US Bio-Tech FAQs
Indo US Bio-Tech share price is ₹125 As on 02 January, 2026 | 07:52
The Market Cap of Indo US Bio-Tech is ₹251.5 Cr As on 02 January, 2026 | 07:52
The P/E ratio of Indo US Bio-Tech is 14.9 As on 02 January, 2026 | 07:52
The PB ratio of Indo US Bio-Tech is 2.9 As on 02 January, 2026 | 07:52
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.